Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank67
3Y CAGR-5.3%
5Y CAGR+88.2%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-5.3%/yr
Annual compound
5Y CAGR
+88.2%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
23.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $332.64M | +71.8% |
| 2024 | $193.63M | -62.6% |
| 2023 | $517.45M | +32.2% |
| 2022 | $391.45M | +270.6% |
| 2021 | $105.61M | +648.8% |
| 2020 | $14.10M | +338.0% |
| 2019 | $3.22M | - |